Iqvia Holdings IQV
NYSE IQV
$269.47 +0.65 (+0.24%)
As of: Sep 17, 2026 · 3:59 PM EDT

Iqvia Holdings (IQV) Non Operating Interest Expenses (2012 - 2026)

Iqvia Holdings' (IQV) quarterly Non Operating Interest Expenses came in at $197.0 million in Q2 2026, up 8.24% year-over-year from $182.0 million in Q2 2025, and up 2.6% quarter-over-quarter from $192.0 million in Q1 2026.

Analysis

Iqvia Holdings (IQV) Non Operating Interest Expenses (2012 - 2026) Analysis & Trends

Iqvia Holdings has disclosed Non Operating Interest Expenses across 15 years of filings, most recently posting $197.0 million for Q2 2026.

  • In Q2 2026, Non Operating Interest Expenses rose 8.24% year-over-year to $197.0 million; the TTM figure through Jun 2026 stood at $771.0 million (up 12.06% YoY), while the FY2025 annual figure was $729.0 million, up 8.81% from the prior year.
  • Non Operating Interest Expenses came in at $197.0 million for Q2 2026 at Iqvia Holdings, up from $192.0 million in the prior quarter.
  • In the past five years, Non Operating Interest Expenses ranged from a high of $197.0 million in Q2 2026 to a low of $86.0 million in Q1 2022.
  • Average Non Operating Interest Expenses over 5 years is $159.8 million, with a median of $169.5 million recorded in 2023.
  • Year-over-year, Non Operating Interest Expenses slipped 13.13% in 2022 and soared 79.79% in 2023.
  • Over 5 years, Non Operating Interest Expenses stood at $128.0 million in 2022, then jumped by 41.41% to $181.0 million in 2023, then decreased by 5.52% to $171.0 million in 2024, then climbed by 12.87% to $193.0 million in 2025, then grew by 2.07% to $197.0 million in 2026.
  • Per Business Quant data, the three most recent Non Operating Interest Expenses figures were $197.0 million in Q2 2026, $192.0 million in Q1 2026, and $193.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 197.00 Mn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn -
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn -48.79 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 30.34 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn -
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn -
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn -
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn -
10 VivoSim Labs 1.37 Mn 1.37 Mn - 4,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 197.00 Mn
Mar 31, 2026 192.00 Mn
Dec 31, 2025 193.00 Mn
Sep 30, 2025 189.00 Mn
Jun 30, 2025 182.00 Mn
Mar 31, 2025 165.00 Mn
Dec 31, 2024 171.00 Mn
Sep 30, 2024 170.00 Mn
Jun 30, 2024 163.00 Mn
Mar 31, 2024 166.00 Mn
Dec 31, 2023 181.00 Mn
Sep 30, 2023 181.00 Mn
Jun 30, 2023 169.00 Mn
Mar 31, 2023 141.00 Mn
Dec 31, 2022 128.00 Mn
Sep 30, 2022 108.00 Mn
Jun 30, 2022 94.00 Mn
Mar 31, 2022 86.00 Mn
Dec 31, 2021 90.00 Mn
Sep 30, 2021 92.00 Mn